Skip to main content
. 2022 Feb 4;13(2):118. doi: 10.1038/s41419-022-04576-4

Fig. 5. PGK1 induces a pro-tumorigenic phenotype in KIRC cells both in vitro and in vivo.

Fig. 5

PGK1 improved cell proliferation (A), clonogenic capacity (B) and migration (C) in 786-O and ACHN cells. Data were presented as the mean ± SD. D The epithelial-mesenchymal transition (EMT) marker proteins were detected in the PGK1-overexpressing RCC cells. E PGK1 overexpression enhanced tumor growth of xenograft mice. Upper panel: tumor growth curve of xenograft mice during inoculation period. 786-O cells stably overexpressing PGK1 or control plasmid were injected subcutaneously into BALB/c nude mice (n = 4), and tumor sizes and morphology were evaluated 5 times after injection. * P < 0.05. Bottom panel: Representative images of xenograft tumors at day 22 after subcutaneous cell injection. F Comparison of Ki-67 staining between 786-O-PGK1 and 786-O-NC cells. G, H Knockdown of PGK1 expression inhibited the cell clonogenic capacity in vitro and the tumorigenicity of 786-O cells in nude mice.